Analyst Articles

If you follow the news avidly, then you’re undoubtedly aware the pharmaceutical industry is currently running off a so-called patent cliff. Problem is, many of the drugs losing their patent protection also happen to be the blockbuster drugs driving the bulk of Big Pharma’s revenue.  It’s not that these large… Read More